Measurements taken over time of prostate specific antigen, the most commonly used screening test for prostate cancer in men, improve the accuracy of aggressive prostate cancer detection when compared ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on disease progression. Among patients with intermediate-risk prostate cancer, ...

With active surveillance, the care team closely watches the cancer rather than starting treatment. This can include PSA ...

Prostate cancer is one of the most common cancers that occur in men. While it can be life-threatening, the disease is treatable, and the earlier it is detected, the better the treatment outcome.

Hormone therapy initiation depends on disease extent; some agents avoid testosterone flare, allowing ADT without Casodex in certain cases. Active surveillance is increasingly chosen for favorable ...

Higher persistent PSA levels post-surgery were linked to increased mortality risk, with 8-year prostate cancer–specific mortality reaching 13.86% for a prostate-specific antigen (PSA) ≥ 1 ng/mL. The ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor Prostate Specific Antigen (PSA) levels. Persistently elevated PSA levels indicate residual cancer and are linked to ...

Mississippi awarded more than $104 million in federal rural health grants across 167 projects. Where the money goes and why rural access matters. Rural Virginia Paramedics Make Home Visits to Cut ...

From 2012 to 2018, the US Preventive Services Task Force (USPSTF) recommended against performing prostate-specific antigen (PSA) testing for prostate cancer screening (D grade). At that time, the ...

Around 1 in 8 men will develop prostate cancer during their lifetime. This common disease develops in the prostate gland and affects millions of men worldwide, especially those over age 50.